Adenovector engineered interleukin-2 expressing autologous plasma cell vaccination after high-dose chemotherapy for multiple myeloma--a phase 1 study (Q43604319)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Adenovector engineered interleukin-2 expressing autologous plasma cell vaccination after high-dose chemotherapy for multiple myeloma--a phase 1 study	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11368448

retrieved

25 November 2017

title

Adenovector engineered interleukin-2 expressing autologous plasma cell vaccination after high-dose chemotherapy for multiple myeloma--a phase 1 study (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11368448

retrieved

25 November 2017

main subject

interleukins

0 references

chemotherapy

1 reference

based on heuristic

inferred from title

author name string

Trudel S

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11368448

retrieved

25 November 2017

Li Z

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11368448

retrieved

25 November 2017

Dodgson C

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11368448

retrieved

25 November 2017

Nanji S

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11368448

retrieved

25 November 2017

Wan Y

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11368448

retrieved

25 November 2017

Voralia M

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11368448

retrieved

25 November 2017

Hitt M

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11368448

retrieved

25 November 2017

Gauldie J

series ordinal

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11368448

retrieved

25 November 2017

Graham FL

series ordinal

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11368448

retrieved

25 November 2017

Stewart AK

series ordinal

10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11368448

retrieved

25 November 2017

publication date

1 May 2001

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11368448

retrieved

25 November 2017

published in

Leukemia

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11368448

retrieved

25 November 2017

volume

15

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11368448

retrieved

25 November 2017

issue

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11368448

retrieved

25 November 2017

page(s)

846-854

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11368448

retrieved

25 November 2017

cites work

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402077

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensification of the stem cell transplant induction regimen results in increased treatment-related mortality without improved outcome in multiple myeloma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402077

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Graft-versus-myeloma effect in two cases

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402077

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Transfer of myeloma idiotype-specific immunity from an actively immunised marrow donor

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402077

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Modulation of anti-idiotypic immune response by immunization with the autologous M-component protein in multiple myeloma patients

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402077

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Paracrine cytokine adjuvants in cancer immunotherapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402077

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Malignant plasma cells are sensitive to LAK cell lysis: pre-clinical and clinical studies of interleukin 2 in the treatment of multiple myeloma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402077

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402077

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402077

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402077

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin-2-mediated modulation of plasma cell tumor growth in a model of multiple myeloma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402077

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Adenovector-mediated gene delivery of interleukin-2 in metastatic breast cancer and melanoma: results of a phase 1 clinical trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402077

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Large scale and clinical grade purification of syndecan-1+ malignant plasma cells

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402077

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Isolation of bone marrow plasma cells by negative selection with immunomagnetic beads

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402077

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunotherapy of metastatic malignant melanoma by a vaccine consisting of autologous interleukin 2-transfected cancer cells: outcome of a phase I study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402077

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Gene therapy with autologous, interleukin 2-secreting tumor cells in patients with malignant melanoma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402077

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1038/SJ.LEU.2402077

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11368448

retrieved

25 November 2017

Dimensions Publication ID

1006772992

0 references

Fatcat ID

release_tbhxwuurbnesxdyp4cwg2jfltm

1 reference

stated in

Fatcat

reference URL

https://api.fatcat.wiki/v0/release/tbhxwuurbnesxdyp4cwg2jfltm

retrieved

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

11368448

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11368448

retrieved

25 November 2017

ResearchGate publication ID

11970613

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43604319&oldid=2206154803"